Karyopharm Therapeutics, Inc. (KPTI)
0.8022
-0.06
(-7.45%)
USD |
NASDAQ |
Oct 02, 16:00
0.8487
+0.05
(+5.80%)
Pre-Market: 20:00
Karyopharm Therapeutics Market Cap : 18.19M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 18.19M |
| October 01, 2026 | 19.66M |
| September 30, 2026 | 27.67M |
| September 29, 2026 | 27.33M |
| September 28, 2026 | 36.74M |
| September 25, 2026 | 36.74M |
| September 24, 2026 | 39.24M |
| September 23, 2026 | 39.69M |
| September 22, 2026 | 41.28M |
| September 21, 2026 | 42.19M |
| September 18, 2026 | 42.64M |
| September 17, 2026 | 40.60M |
| September 16, 2026 | 38.56M |
| September 15, 2026 | 34.93M |
| September 14, 2026 | 36.29M |
| September 11, 2026 | 36.52M |
| September 10, 2026 | 36.74M |
| September 09, 2026 | 38.33M |
| September 08, 2026 | 39.01M |
| September 04, 2026 | 40.60M |
| September 03, 2026 | 40.14M |
| September 02, 2026 | 40.60M |
| September 01, 2026 | 41.96M |
| August 31, 2026 | 46.72M |
| August 28, 2026 | 42.41M |
| Date | Value |
|---|---|
| August 27, 2026 | 44.00M |
| August 26, 2026 | 44.45M |
| August 25, 2026 | 43.55M |
| August 24, 2026 | 42.19M |
| August 21, 2026 | 44.45M |
| August 20, 2026 | 41.28M |
| August 19, 2026 | 45.36M |
| August 18, 2026 | 43.77M |
| August 17, 2026 | 41.05M |
| August 14, 2026 | 45.81M |
| August 13, 2026 | 45.13M |
| August 12, 2026 | 46.04M |
| August 11, 2026 | 47.63M |
| August 10, 2026 | 44.45M |
| August 07, 2026 | 47.79M |
| August 06, 2026 | 43.96M |
| August 05, 2026 | 43.06M |
| August 04, 2026 | 44.19M |
| August 03, 2026 | 44.41M |
| July 31, 2026 | 43.28M |
| July 30, 2026 | 158.03M |
| July 29, 2026 | 154.65M |
| July 28, 2026 | 159.84M |
| July 27, 2026 | 159.84M |
| July 24, 2026 | 167.05M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Madrigal Pharmaceuticals, Inc. | 11.53B |
| Relay Therapeutics, Inc. | 4.143B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
Market Cap Related Metrics
| PS Ratio | 0.1097 |
| PEG Ratio | -0.0033 |
| Price | 0.8022 |
| Earnings Yield | -1.63K% |
| PEGY Ratio | -0.0033 |